Levosimendan: Nueva estrategia en el manejo de la falla cardíaca

González-Chon, Octavio; García López, Sandra María del Carmen; Chacón Mercado, Marco Alejandro; Arias Sánchez, Eduardo Agustín; Vega Zapata, Reyna Estela.
Arch. cardiol. Méx ; 75(supl.3): 130-139, jul.-sep. 2005. tab
Artículo en Español | LILACS | ID: lil-631933

Documentos relacionados

  1. Inotropes in Patients with Advanced Heart Failure: Not Only Palliative Care.
  2. Repeated Levosimendan Infusions in the Management of Advanced Heart Failure: Review of the Evidence and Meta-analysis of the Effect on Mortality.
  3. [Levosimendan - a 20-Year Experience].
  4. Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?
  5. [Levosimendan: a new strategy in the treatment of heart failure].
  6. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.
  7. Effectiveness and safety of levosimendan in clinical practice.
  8. Effect of Levosimendan Treatment in Pediatric Patients With Cardiac Dysfunction: An Update of a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
  9. Acetylation status does not affect levosimendan's hemodynamic effects in heart failure patients.
  10. Levosimendan in daily intensive care practice--the experience of 15 centers. Background, methods and organization of the PORTLAND study.